IL-6 Receptor Polymorphisms May Be Associated With Aortic Aneurysm Risk
Identification of interleukin 6 receptor single-nucleotide polymorphisms was associated with a significantly reduced risk for aortic aneurysm phenotypes.
Genetics
Familial Hypercholesterolemia Benefits From Genetic Screening
Genetic screening for familial hypercholesterolemia would improve the likelihood of a definitive diagnosis and may help clinicians choose the appropriate therapy for patients.
Genetic Screening in Preventive Care: Advances and Challenges
Approximately 1% of individuals in the United States have a genetic predisposition to cancer or heart disease, and these individuals could be ideal candidates for genetic screening.
High-Risk APOL1 Not Tied to CHD, Stroke in Postmenopausal Black Women
High-risk APOL1 genotype was linked to HFpEF hospitalization in postmenopausal black women.
Genomic Medicine Will Help Shift Cardio Care to Proactive Approach
Within 2 decades, many patients are likely to undergo routine cardiovascular genomic testing.
More Variants in Dilated Cardiomyopathy-Tied Genes in Alcoholic Cardiomyopathy
A combination of titin truncating variants and excess alcohol consumption linked with worse LVEF in dilated cardiomyopathy.
High FGF-23 Linked to Recurrent Cardiac Events After ACS
FGF-23 concentrations in the top quartile were independently linked to greater risk for CV death and heart failure hospitalization.
Genotype-Guided Antiplatelet Therapy Feasible, Effective
Genotype-guided therapy improved outcomes in patients who were CYP2C19 intermediate and poor metabolizers.
Fewer SIDS Cases Result From Genetic Heart Disease Causes
Fewer cases of sudden infant death syndrome may be linked to genetic heart diseases than previously thought.
Coronary Heart Disease Risk Linked to Higher FGF23 Levels
After adjustment for established coronary heart disease risk factors and kidney function, higher fibroblast growth factor 23 concentrations were correlated with an increased risk for coronary heart disease.
